BiotechTube
Home/Actym Therapeutics/Mary J. Janatpour, PhD
MJ

Mary J. Janatpour, PhD

Chief Scientific Officer

Actym Therapeutics

Therapeutic Areas

OncologyFibrotic Diseases

Actym Therapeutics Pipeline

DrugIndicationPhase
ACTM-838Advanced Solid TumorsPhase 1a/1b

Leadership Team at Actym Therapeutics

SV
Steve Vicik, PhD
Chief Technical Officer
S'
Shouryadeep 'Deep' Srivastava, MD, PhD
Senior Vice President of Clinical Development
JM
Julie M. Cherrington, PhD
Board Chair
View full Actym Therapeutics profile